These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 9922344)

  • 1. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction.
    Rademaker MT; Cameron VA; Charles CJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM
    Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H731-40. PubMed ID: 10710340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
    J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
    Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
    Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
    Choy AM; Darbar D; Lang CC; Pringle TH; McNeill GP; Kennedy NS; Struthers AD
    Br Heart J; 1994 Jul; 72(1):16-22. PubMed ID: 7741839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
    Hall C; Rouleau JL; Moyè L; de Champlain J; Bichet D; Klein M; Sussex B; Packer M; Rouleau J; Arnold MO
    Circulation; 1994 May; 89(5):1934-42. PubMed ID: 8181115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.